Evidence map›Paper›PMID 31138574›Full record

ArticleAntimicrobial agents and chemotherapy2019

The Likelihood of Developing a Carbapenem-Resistant

Pranita D Tamma, Abida Kazmi, Yehudit Bergman, Katherine E Goodman, Ernest Ekunseitan, Joe Amoah, Patricia J Simner

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04873557 (Copper Use as Protection Against Antimicrobial Resistance in the ICU), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04873557 nacompletednot on this mapstarted 2020, after this paper: background citation

Copper Use as Protection Against Antimicrobial Resistance in the ICU

TypeinterventionalSponsorUniversidad del DesarrolloRan2020 to 2022Enrolled168ConditionsHealthcare Associated InfectionArmsCopper-based surfaces plus copper-enriched linen
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Improved diagnostic stewardship in carbapenem-resistantJournal of medical microbiology · 2025
    Article
  2. Impact of XpertFrontiers in cellular and infection microbiology · 2025
    Observational
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Combined selective culture and molecular methods for the detection of carbapenem-resistant organisms from fecal specimens.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Article
  11. Article
  12. Frequency of and risk factors for carbapenem-resistantJournal of medical microbiology · 2021
    Article
  13. Prolonged Carriage of Carbapenemase-ProducingJournal of clinical medicine · 2021
    Article
  14. Molecular Epidemiology of Carbapenemases inAntibiotics (Basel, Switzerland) · 2020
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Pranita D TammaDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA ptamma1@jhmi.edu psimner1@jhmi.edu.
Abida KazmiDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Yehudit BergmanDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Katherine E GoodmanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ernest EkunseitanDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Joe AmoahDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Patricia J SimnerDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA ptamma1@jhmi.edu psimner1@jhmi.edu.
Johns Hopkins Medicine · USJohns Hopkins University · US

Funding

The Use of MALDI TOF for the Rapid Detection of Carbapenemases from Clinical IsolatesK23AI127935 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TAMMA, PRANITA · 2017 to 2020
$734k
Real-Time Whole Genome Sequencing Analysis of Carbapenemase-Producing Organisms in the Non-Outbreak Hospital SettingR21AI130608 · NIAID · JOHNS HOPKINS UNIVERSITY · PI SIMNER, PATRICIA · 2017 to 2018
$449k
NIAID NIH HHS K23 AI127935NIAID NIH HHS R21 AI130608
6 · The paper itself

Abstract

Of 1,455 unique patients in U.S. intensive care units (ICUs), 4% were rectally colonized with CRE on admission. A total of 297 patients were initially negative for carbapenem-resistant

Indexed as

Bacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeCarbapenemsEnterobacteriaceae InfectionsIntensive Care UnitsLength of StayBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemscarbapenem resistanceCREICUmultidrug-resistant organisms

Identifiers

PMID31138574
PMCPMC6658786
OpenAlexW2946763797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.